Jaguar Health, Inc. (NASDAQ:JAGX) reached 143.48% versus a 1-year low price of $0.12. The stock was last seen 2.71% higher, reaching at $0.28 on 01/11/2019. At recent session, the prices were hovering between $0.275 and $0.305. This company shares are 346.43% off its target price of $1.25 and the current market capitalization stands at $9M. The recent change has given its price a -24.08% deficit over SMA 50 and -95.76% deficit over its 52-week high. The stock witnessed -6.6% declines, -46.15% declines and -81.08% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found JAGX’s volatility during a week at 16.44% and during a month it has been found around 20.73%.Jaguar Health, Inc. (JAGX) Top Holders
Institutional investors currently hold around $1 million or 14.2% in JAGX stock. Look at its top three institutional owners. Invesco Ltd. owns $505 thousand in Jaguar Health, Inc., which represents roughly 5.61% of the company’s market cap and approximately 50.5% of the institutional ownership. Similar statistics are true for the second largest owner, Burford Capital Investment Management Llc, which owns 1,231,988 shares of the stock are valued at $345 thousand. The third largest holder is Howard Capital Management, which currently holds $14 thousand worth of this stock and that ownership represents nearly 0.16% of its market capitalization.
At the end of September reporting period, 10 institutional holders increased their position in Jaguar Health, Inc. (NASDAQ:JAGX) by some 1,041,048 shares, 4 decreased positions by 453,114 and 3 held positions by 1,793,128. That puts total institutional holdings at 3,287,290 shares, according to SEC filings. The stock grabbed 5 new institutional investments totaling 102,472 shares while 4 institutional investors sold out their entire positions totaling 453,114 shares.Jaguar Health, Inc. (NASDAQ:JAGX) Insider Trades
Multiple company employees have indulged in significant insider trading. Jaguar Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Siegel Jonathan B. has acquired 25,000 shares of Jaguar Health, Inc. (JAGX) in trading session dated Oct. 04, 2018. These shares are worth $15,000 and were traded at $0.6 each. The SEC filing shows that Nantucket Investments Ltd performed a sale of 325,615 shares. The 10% Owner disposed these shares by way of transaction on Sep. 25, 2018. The company’s shares were given away at $1.83 per share worth to an income of some $595,875 on account of Nantucket Investments Ltd.
Director, Siegel Jonathan B., purchased 5,000 common shares of Jaguar Health, Inc. (JAGX) in the open market. In a transaction dated Jul. 18, 2018, the shares were bought at an average price of $1.1, giving away a sum of $5,500. After this purchase, 14,732 common shares of JAGX are directly owned by the insider, with total stake valued at $4,125.
In the transaction dated Jul. 18, 2018, the great number of shares acquired came courtesy the CEO and President; Conte Lisa A added a total of 1,500 shares at an average price of $1.11, amounting to approximately $1,665. The insider now directly owns 7,500 shares worth $2,100.